CPT 51721 TULSA Reimbursement & Policy | OpenPayer

Summary & Overview

CPT 51721: Transurethral Ultrasound Ablation (TULSA) of Prostate

CPT code 51721 represents transurethral ultrasound ablation (TULSA) of prostate tissue, a minimally invasive, image-guided thermal ablation procedure performed through a urethral transducer. This code captures the core technical act of inserting the transducer and performing the ablation and may include adjunctive measures such as suprapubic bladder drainage and endorectal cooling to protect adjacent structures. Nationally, TULSA is notable for its role in focal and whole-gland prostate tissue ablation as an alternative to more invasive surgical approaches.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will gain a concise understanding of the clinical procedure CPT code 51721 represents, typical sites of service, and the payer landscape relevant to authorization and coverage considerations. The publication provides benchmarks where available, summarizes policy themes and coverage drivers, and outlines the clinical context that influences coding and payment for image-guided prostate ablation. Data not available in the input is clearly flagged when needed.

AetnaBlue Cross Blue ShieldCignaUnitedHealthcareMedicare51721CPTprostate-ablationTULSAtransurethral-procedureimage-guided-therapyurologyambulatory-surgery

Billing Code Overview

CPT code 51721 describes the insertion of a transducer into the urethra to perform transurethral ultrasound ablation (TULSA) of prostate tissue. The procedure may include placement of a suprapubic tube for bladder drainage and use of an endorectal cooling device to protect surrounding tissues during the ablation.

Service type: Image-guided transurethral thermal ablation procedure of the prostate
Typical site of service: Hospital outpatient department or ambulatory surgery center specializing in urologic or interventional procedures

Clinical & Coding Specifications

Clinical Context

A typical patient is a 60–75-year-old man with symptomatic localized prostate disease (for example, bothersome urinary obstruction or biopsy-proven localized prostate cancer) who elects focal or whole-gland transurethral ultrasound ablation (TULSA). The clinical workflow begins with preprocedural evaluation including prostate MRI, serum prostate-specific antigen (PSA), and urology consultation to confirm lesion location and candidacy for TULSA. On the day of service the patient is brought to an ambulatory surgical center or hospital operating room for the procedure under general or monitored anesthesia care. The urologist and procedural team place a transurethral ultrasound transducer into the urethra to deliver targeted thermal ablation to prostate tissue. An indwelling suprapubic tube may be placed for bladder drainage if indicated, and an endorectal cooling device may be positioned to protect adjacent rectal tissues during energy delivery. Intraoperative ultrasound imaging and temperature monitoring guide ablation. Postprocedure care includes short-term catheter drainage, observation for urinary retention or bleeding, pain control, and follow-up visits with PSA monitoring and imaging as indicated. Typical sites of service are the hospital operating room or an accredited ambulatory surgical center depending on patient comorbidity and facility capabilities.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier (default)	Use when no special reporting modifier is required for the claim.

CPT 51700: Bladder Irrigation and Instillation

CPT-51715-ENDOSCOPIC-URETHRAL-BLADDER-NECK-INJECTION-INCONTINENCE

CPT 51715: Endoscopic Urethral/Bladder Neck Injection for Incontinence

CPT-51610-URETHROCYSTOGRAPHY-URETHRA-BLADDER-CONTRAST-STUDY

CPT 51610: Urethrocystography, Retrograde Contrast Study of Urethra and Bladder

CPT-51702-BLADDER-CATHETERIZATION-PLACEMENT-MANAGEMENT

CPT 51702: Bladder Catheterization Placement and Management

CPT-51710-COMPLICATED-BLADDER-CATHETER-REPLACEMENT

CPT 51710: Complicated Bladder Catheter Removal and Replacement

CPT-51605-URETHROCYSTOGRAPHY-CONTRAST-INSTILLATION-WITH-CHAIN-PLACEMENT

CPT 51605: Urethrocystography With Contrast Chain Placement

CPT-51701-INTERMITTENT-URINARY-CATHETERIZATION-RESIDUAL-URINE

CPT 51701: Intermittent Urinary Catheterization for Residual Urine

CPT-51600-VOIDING-CYSTOURETHROGRAM-VCUG-MCUG

CPT 51600: Voiding Cystourethrogram (VCUG)

CPT-51705-BLADDER-TUBE-REPLACEMENT-SIMPLE-EXCHANGE

CPT 51705: Simple Bladder Tube Exchange

51720-BLADDER-INSTILLATION-OF-ANTICARCINOGENIC-AGENT-INCLUDING

CPT 51720: Bladder Instillation of Anticarcinogenic Agent

Showing 1–10 of 11

Taxonomy Code	Specialty	Notes
208600000X	Urology	Primary specialty performing TULSA procedures.
208800000X	Radiation Oncology	May be involved for multidisciplinary prostate cancer care and planning.
207R00000X	Diagnostic Radiology	Provides MRI/ultrasound imaging support and intraoperative imaging guidance.
363LF0000X	Anesthesiology	Provides general or monitored anesthesia care during the procedure.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`N40.0`	Enlarged prostate with lower urinary tract symptoms	Benign prostatic hyperplasia causing urinary obstruction may be treated with prostate ablation techniques including TULSA.
`C61`	Malignant neoplasm of prostate	Localized prostate cancer is a primary indication for targeted thermal ablation such as TULSA in selected patients.
`N13.8`	Other obstructive and reflux uropathy	Obstructive uropathy related to prostate enlargement may prompt consideration of ablative procedures for symptomatic relief.
`N32.9`	Disease of bladder, unspecified	Coexisting bladder dysfunction may be evaluated before and after prostate ablation for urinary symptom management.
`R33.9`	Retention of urine, unspecified	Acute or chronic urinary retention can be an indication for procedural intervention that may include prostate tissue ablation to relieve obstruction.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`51702`	Insertion of temporary indwelling bladder catheter; simple (e.g., Foley)	May be performed pre- or postprocedure for bladder drainage when urethral catheterization is used instead of suprapubic tube.
`51701`	Introduction of cystostomy tube (e.g., suprapubic catheter), without cystoscopy	Used when a suprapubic tube is placed for bladder drainage as allowed in the TULSA description.
`76930`	Ultrasonic guidance for needle placement (e.g., biopsy, aspiration, injection), imaging supervision and interpretation	May be used for intraoperative ultrasound guidance or imaging supervision if billing separate guidance services per payer policy.
`51721`	Insertion of transducer in urethra for transurethral ultrasound ablation (TULSA) of prostate tissue	Primary procedure code describing transurethral ultrasound ablation transducer insertion and associated protective devices.
`51725`	Measurement of residual urine and bladder capacity (e.g., by catheterization and irrigation; simple)	May be performed in pre- or postprocedure assessment of bladder emptying and urinary retention.

OpenPayer